In Memoriam
John Segreti, MD
John Segreti, MD died on June 16th at Rush University Medical Center of an illness that he bravely battled for over a decade.
I had the pleasure of meeting and befriending John in 1976. We attended medical school and completed our internal medicine residency and infectious disease fellowship together at Rush. John stayed as faculty at Rush where he accepted many challenges, was a professor of medicine, and most recently the president of the Rush medical staff. He was best known for his intelligence, clinical excellence, and practicality in the face of confusion. John was the physician that other doctors asked for advice. With an overtly affable personality and an encyclopedic knowledge of infectious disease, he solved countless clinical conundrums.
John was the Editor in Chief of our medical journal – Private Practice Infectious Disease. From the onset, he directed the journal with sensibility, mentorship, and clinical contributions. Most recently he wrote an editorial in support of infectious disease private practice.
During the pandemic, John directed the infection control efforts at Rush. He was credited by senior management with a direct but definitive approach that allowed them to continue operations despite the tumultuous events.
John’s greatest passion was his family. His wife of over forty years, Jeanne; his three children – Dania, Giancarlo, and Stefan; and his two grandchildren – Ava and Liam. He also loved sports, including boxing, ballroom dancing, and especially baseball. The White Sox were his team, and regardless of their performance, John remained one of their most loyal fans.
When talking to John, it was impossible to detect the state of his health. He never complained and always had a positive demeanor when discussing his illness. He leaves behind a legacy of medical expertise, professional collegiality, and family love. He will be missed by the infectious disease community, MIDC, and all those that knew and loved him.
– Russell Petrak, M.D.
Editor in Chief
Russell Petrak, MD
Editorial Board Member
Dr. Russell Petrak is an Infectious Disease Physician and Managing partner of Metro Infectious Disease Consultants. He completed his residency and fellowship at Rush University Medical Center. His clinical interssts have been primarily Outpatient Parenteral Antibiotic Therapy, SARS-CoV-2, and Fever of Unknown Origin. He was previously Chairman of the IDSA Clinical Affairs Committee, and has lectured extensively on Infectious disease physician enhancements.
Editorial Board Members
Robert Fliegelman, DO
Editorial Board Member
Dr. Robert Fliegelman is a practicing Infectious Physician and a member of the Metro Infectious Disease Consultants Management Committee since its inception. He completed his Internal Medicine Residency at Chicago Osteopathic Medical Center, and his Infectious Disease Fellowship at Rush University. His clinical interests include surgical site infections, COVID, and Outpatient Parenteral Antibiotic Therapy. He previously served on the IDSA Clinical Affairs Committee, and was part of the Faculty for the IDSA Fellows Meeting.
David Hines, MD
Editorial Board Member
Dr. David W Hines began his Medical career in Guadalajara Mexico for two years, then transferred to Rush Medical School where he graduated in 1981. He remained there for an Internal Medicine Residency, Chief Medical Residency and an Infectious Disease Fellowship. Along with Russ Petrak and Robert Fliegelman, he helps manage Metro Infectious Disease Consultants.
Associate Editors
Mariam Aziz, MD
Associate Editor
Dr. Mariam Aziz is an Associate professor in the department of Internal Medicine, Division of Infectious Diseases and the Division of Community and Global Health Equity and the Department of Pediatrics. She is the combined Rush/Cook County Health Infectious Diseases fellowship program Director. She participates in research as site Principal Investigator with IMPAACT (The International Maternal Pediatric Adolescent AIDS Clinical Trials group), a global collaboration of investigators and institutions with the purpose of conducting clinical trials treat and prevent HIV infection and its consequences in infants, children, adolescents and pregnant/postpartum women. She is a co-investigator with the adult AIDS Clinical Trials Group and has done clinical trials involving RSV and SARS-CoV-2 treatments. She has clinical expertise in HIV infection as well as Pre-exposure prophylaxis for HIV. She has clinical experience in the management of Pediatric HIV infection and in prevention of maternal to child transmission of HIV. She also has interest in Global Health and Tropical Infectious Diseases.
Vishal Didwania, MD
Associate Editor
Dr. Vishal Didwania is an Infectious disease physician with Metro Infectious Disease Consultants (MIDC) and completed his residency and fellowship at Rush University Medical Center. He is the chair of the MIDC Antibiotic Stewardship program and also leads infection control and stewardship at a local hospital and extended care facility. He has an active infectious disease practice. Clinical and Research interests include Osteomyelitis, clostridium difficile, SARS-CoV-2, and management of complicated infections.
Alice Han
Associate Editor
Dr. Alice Han received her medical degree from the University of Michigan in 2005. She completed her Internal Medicine residency at St. Luke’s Roosevelt Hospital in New York City in 2008. Dr. Han completed her Infectious Disease fellowship at Rush University Medical Center in 2011. She is a practicing Infectious Disease physician at Metro Infectious Disease Consultants (MIDC). Dr. Han is the Director of the MIDC Transplant Committee. She served as the medical director of Infection Prevention and the Antibiotic Stewardship at Gottlieb Memorial hospital for 6 years. Dr. Han worked closely with IDPH and the CDC from 2017-2020 on the MDRO task force in conjunction with Rush and the Chicago PROTECT study addressing MDROs in the long term care facilities. Her research and clinical interests include infections in the hematopoietic stem cell transplant population, Infection Prevention practices, SARS-CoV-2 and HIV/AIDS.
Brian Harting, MD
Associate Editor
Dr. Brian Harting is an Infectious Disease physician at Metro Infectious Disease Consultants (MIDC). He is the Director of Infection Prevention Quality Committee. He serves as Medical Director of Infection Prevention and Antibiotic Stewardship at Good Samaritan Hospital in Downers Grove, IL. His clinical and research interests include infection prevention policies and clinical practice guidelines, and evaluation and treatment of orthopedic infections. Prior to joining MIDC, he was an Infectious Disease Fellow at Rush University Medical Center. He then served as Assistant Professor of Medicine in the Division of Infectious Diseases as well as Co-Director of Patient Safety Research in the Department of Medicine at Rush.
David McKinsey, MD
Associate Editor
Dr. David McKinsey received his medical degree from the University of Missouri-Columbia and completed an Internal Medicine residency at the University of Iowa and an Infectious Diseases fellowship at the University of Tennessee-Memphis. He is Regional Medical Director for Metro Infectious Disease Consultants- Kansas City, hospital epidemiologist at Research Medical Center, Clinical Professor of Medicine at the University of Kansas, and Infectious Diseases consultant at the Stowers Institute for Medical Research. Dr. McKinsey has been actively engaged in medical research and education throughout his career and has published many manuscripts and book chapters.
Ingrid Roig, MD
Associate Editor
Dr. Ingrid Roig is an infectious disease physician with Metro Infectious disease physician with Metro Disease Consultants (MIDC). She completed her specialty and subspecialty training at Baylor College of Medicine. She is the clinical director at her infectious disease practice in Huntsville, Alabama. Her clinical and research interest include device associated infection, mycobacterial disease, novel viral infections including SARS-CoV-2, fungal and bacterial infection in the immunocompromised host.
Kairav Shah, MD, FACP, FIDSA
Associate Editor
Dr. Kairav Shah is an Infectious disease physician based in Atlanta, GA. He completed his internal medicine residency from the Guthrie Clinic/Robert Packer Hospital in Pennsylvania and his infectious disease fellowship from the University of Florida in Gainesville, FL. He is a former Assistant Professor of Medicine at University of Florida where he also served as Medical Director of the ID clinic and ran a joint Orthopedics-Infectious Disease clinic. He chairs the pharmacy and therapeutics committee, antimicrobial stewardship and infection prevention committees at the local hospital he serves. His clinical and research interests include bone and joint infections, infections in immunocompromised host, HIV/AIDS, urinary tract infections, mycobacterial infections and has co-authored several peer-reviewed publications on these.
Kamo Sidhwa, MD
Associate Editor
Dr. Kamo Sidhwa has been a practicing ID physician with Metro Infectious Disease Consultants (MIDC) since 2007. She previously served as Co-Medical Director of Infection Prevention and Antibiotic Stewardship at Advocate South Suburban Hospital for several years, and currently is active on the CME and Antibiotic Stewardship Committees at MIDC. Prior to joining MIDC, she completed her Internal Medicine Residency at William Beaumont Hospital and her Infectious Disease Fellowship at Rush University Medical Center. Clinical and research interests include intra abdominal and surgical site infections.
Nathan Skorodin, PharmD
Associate Editor
Dr. Nathan Skorodin is a pharmacist with Metro Infectious Disease Consultants (MIDC). Former director for a home infusion and specialty services pharmacy. Lead coordinator for the MIDC continuing medical education committee and member of the antibiotic stewardship committee. Research interests include SARS-CoV-2 and outpatient antimicrobial therapy.
Nicholas Van Hise, PharmD
Associate Editor
Dr. Nicholas Van Hise is an Infectious disease pharmacist with Metro Infectious Disease Consultants (MIDC) and completed his residencies at Mercy Hospital St. Louis, and Indiana University Health for his board certification in Infectious disease. He is the director of the clinical research department at MIDC where he has run over 20 clinical trials, from Phase I to post approval, Phase IV trials. He also collaborates to run the Antibiotic Stewardship Program and provide continuing medical education to the providers within MIDC. He has published numerous times on topics including clostridium difficile, antimicrobial resistance, SARS-CoV-2, Osteomyelitis, prosthetic joing infections, and others.
